Talk:CD27

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is within the scope of the Cell Signaling task force, a task force which is currently considered to be inactive.

Wiki Education Foundation-supported course assignment

This article was the subject of a Wiki Education Foundation-supported course assignment, between 4 January 2021 and 15 March 2021. Further details are available on the course page. Student editor(s): Immcarle156.

Above undated message substituted from Template:Dashboard.wikiedu.org assignment by PrimeBOT (talk) 16:29, 16 January 2022 (UTC)[reply]

What cell types is it found on

? - Rod57 (talk) 12:08, 22 October 2015 (UTC)[reply]

Edits in progress

I will be adding new information to this page in the coming weeks. Below are the sources I will be using.

Buchan, S. L., Rogel, A., and Al-Shamkhani, A. (2018). The immunobiology of CD27 and OX40 and their potential as targets for cancer immunotherapy. Blood 131, 39-48. https://doi.org/10.1182/blood-2017-07-741025

Bullock, T. N. J. (2017). Stimulating CD27 to quantitatively and qualitatively shape adaptive immunity to cancer. Curr. Opin. Immunol. 45, 82-88. https://doi.org/10.1016/j.coi.2017.02.001

Burugu, S., Dancsok, A. R., and Nielsen, T. O. (2018). Emerging targets in cancer immunotherapy. Semin. Cancer Biol. 52, 39-52. https://doi.org/10.1016/j.semcancer.2017.10.001

Sturgill, E. R. and Redmond, W. L. (2017). TNFR Agonists: A Review of Current Biologics Targeting OX40, 4-1BB, CD27, and GITR. AJHO 13, 4-15.

--Immcarle156 (talk) 17:04, 29 January 2021 (UTC)[reply]